Hereditary Transthyretin Amyloidosis Market Expected to Flourish with New Treatments The hereditary transthyretin amyloidosis market is set for significant growth, driven by awareness and new therapies, including CRISPR-based treatments.

Hereditary Transthyretin Amyloidosis Market Expected to Flourish with New Treatments #USA #Las_Vegas #gene_therapy #Amyloidosis #hATTR

Prevalence and Phenotype of Transthyretin Val122Ile Variant in the Hispanic Community Health Study/Study of Latinos:

Our new paper in JACC: Advances 🧬
First study to examine TTR Val122Ile in community-dwelling Hispanic/Latino adults.
Carriers were mostly of Dominican background, reflecting higher African ancestry, and identifying a group at risk for hATTR!
🔗 www.jacc.org/doi/10.1016/...
#hATTR #Genomics #HCHSSOL

4/4: And from the session, #HealthDisparities in #hATTR… 3% of U.S. Black patients carry the V122I variant for #ATTR. #ACC.25 #CardioSky #Cardiology @accintouch.bsky.social